ClinicalTrials.gg
RecruitingNCT07726108Updated Jul 24, 2026

Digital Anticipatory Protocols at Triage to Improve ED Flow.

An observational study in Length of Stay, Emergency Department Crowding and Emergency Department Patient, sponsored by Hôpital Fribourgeois. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Hôpital Fribourgeois · Observational

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
15,500
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate a pre-post intervention adding an early management decision at the end of the triage process to improve patient throughput. The intervention consists of adding digital checkboxes to the electronic triage system, providing nurses with formalized options for anticipated management based on patient acuity. The study compares a pre-intervention phase (May 1st to July 31st, 2026) with a post-intervention phase (May 1st to July 31st, 2027) to naturalize seasonal confounders. The primary outcome is the total Emergency Department Length of Stay (ED LOS).

02

Conditions studied

  • Length of Stay
  • Emergency Department Crowding
  • Emergency Department Patient
  • Emergency Department Triage
  • Nurses
  • Workflow
  • Diagnostic Tests

Browse trials for

03

In context

Crowding

89 studies on the registry are indexed under Crowding; 23 are open to participants now.

This study's planned enrollment of 15,500 is above the median of 664 across 14 observational studies indexed under Crowding.

Browse Crowding studies →

Lead sponsor

Hôpital Fribourgeois is the lead sponsor of 18 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population comprises all adult patients (over 18 years old) presenting to the emergency department of the cantonal hospital in Fribourg (HFR), Switzerland, during the predefined study periods (Phase 1 and Phase 2). The HFR is a university teaching and research hospital that manages approximately 41,000 ED visits annually.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients over 18 years who registered at the admission desk during the study period.

Exclusion criteria

Exclusion Criteria:

  • Arrival by emergency medical services (ambulance or helicopter)
  • Patient trajectory bypassing the standard nurse-led triage process
  • Patient directly referred to another service of the hospital after triage (gynecology, ophthalmology, etc.).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
15,500 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Phase 1 - Pre-intervention

    Patients presenting to the emergency department between May 1st and July 31st, 2026. Patients undergo standard triage assessment performed using the revised Swiss Emergency Triage Scale (SETS). Disposition decisions are monitored using a digital tag in the electronic health records.

  • Phase 2 - Post-intervention

    Patients presenting to the emergency department between May 1st and July 31st, 2027. Patients undergo triage with the addition of a new digital anticipatory protocol. Disposition decisions continue to be monitored using the same digital tag.

    Procedure: Digital Anticipatory Protocols at Triage

Interventions

  • ProcedureDigital Anticipatory Protocols at Triage

    The intervention consists of adding digital checkboxes to the electronic triage system. This provides nurses with formalized options for anticipated management based on patient acuity, aiming to encourage and document anticipatory actions while stimulating clinical reasoning.

06

What researchers measure

Primary outcomes

  1. Total Emergency Department Length of Stay (ED LOS).

    The time interval from the completion of the patient's administrative registration to their physical departure from the ED

    Time frame: Through completion of the ED visit, up to a maximum of 72 hours.

Secondary outcomes

  1. Left without being seen (LWBS)

    Proportion of patients who registered at the ED admission desk and left before receiving a medical screening exam or an evaluation by a physician

    Time frame: Through completion of the ED visit, up to a maximum of 72 hours.

  2. 30-day mortality

    Assessed through institutional medical records to evaluate safety

    Time frame: Up to 30 days post-ED visit

  3. Intesive Care Unit (ICU) transfers

    Proportion of patients transferred to the Intensive Care Unit (ICU) immediately and within 7 days after the ED visit

    Time frame: Up to 7 days post-ED visit

Other outcomes

  1. Time From Triage Assessment to Disposition Decision

    The time interval, measured in minutes, elapsed from the beginning of the nursing triage assessment to the exact moment a definitive disposition decision (e.g., discharge, admission) is entered by the emergency physician. A disposition decision is operationally defined as the precise moment the attending emergency physician determines that active emergency care is complete. This includes the decision to transfer the patient to a hospital ward (for admissions) or the conclusion of clinical management (for discharges), even if the patient remains in the emergency department awaiting purely logistical arrangements, such as medical transport or family arrival. The measurement tool used to assess and timestamp this outcome is a standardized digital disposition decision tag integrated into the electronic health record.

    Time frame: Through completion of the ED visit, up to a maximum of 72 hours.

  2. Time From Treatment Room Placement to Disposition Decision

    The time interval, measured in minutes, elapsed from when the patient is placed in an ED treatment room to the exact moment a definitive disposition decision (e.g., discharge, admission) is entered by the emergency physician. A disposition decision is operationally defined as the precise moment the attending emergency physician determines that active emergency care is complete. This includes the decision to transfer the patient to a hospital ward (for admissions) or the conclusion of clinical management (for discharges), even if the patient remains in the emergency department awaiting purely logistical arrangements, such as medical transport or family arrival. The measurement tool used to assess and timestamp this outcome is a standardized digital disposition decision tag integrated into the electronic health record.

    Time frame: Through completion of the ED visit, up to a maximum of 72 hours.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Data sharing is restricted by the Swiss Human Research Act and local ethics committee (Swissethics) due to the retrospective/observational nature of this quality improvement project and the lack of explicit patient consent for public open-data sharing.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Jul 2027, 14 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Jul 24, 2026
StartActual
May 1, 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Jul 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07726108
Lead sponsor
Hôpital Fribourgeois
Collaborators
University of Fribourg
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
May 1, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Jul 24, 2026

Study contacts

Thomas Castelain
Contact
thomas.castelain@h-fr.ch
+41263061392
Youcef Guechi
Contact
youcef.guechi@h-fr.ch
+41263063142
Youcef Guechi, MD
principal investigator · Hopital Cantonal Fribourgeois (HFR)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion